Search for Clinical Trial Results

Sponsored By

Congenital Mesoblastic Nephroma - 5 Studies Found

Status Study
Withdrawn Study Name: Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
Condition:
  • Clear Cell Renal Cell Carcinoma
  • Congenital Mesoblastic Nephroma
    Date: 2012-07-15
    Interventions: Other: laboratory biomarker analysis Correlative studies
Recruiting Study Name: Study of Kidney Tumors in Younger Patients
Condition:
  • Clear Cell Sarcoma of the Kidney
  • Congenital Mesoblastic Nephroma Date: 2009-05-09
    Interventions:
    • Other: laboratory biomarker analysis

Recruiting Study Name: Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Condition:
  • Solid Tumors
  • CNS Tumors
  • Neuroblastoma

Date: 2016-01-04
Interventions: Drug: Entrectinib TRKA/B/C, ROS1, and ALK inhibitor
Recruiting Study Name: Oral TRK Inhibitor LOXO-101 (Larotrectinib) for Treatment of Advanced Pediatric Solid or Primary Central Nervous System Tumors
Condition:
  • Neoplasms
  • Central Nervous System Neoplasms

Date: 2015-12-10
Interventions: Drug: LOXO-101 (larotrectinib) Capsules / Liquid Administration
Active, not recruiting Study Name: Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Condition:
  • Bladder Cancer
  • Brain and Central Nervous System Tumors
  • Eso
    Date: 2008-09-22
    Interventions:
    • Genetic: DNA analysis
    • Genetic: polymorphis